No abstract available
Publication types
-
Clinical Trial
-
Clinical Trial, Phase II
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Cerebrovascular Disorders / drug therapy*
-
Cerebrovascular Disorders / physiopathology
-
Dose-Response Relationship, Drug
-
Double-Blind Method
-
Humans
-
Infusions, Intravenous
-
Neuroprotective Agents / administration & dosage
-
Neuroprotective Agents / therapeutic use
-
Neuroprotective Agents / toxicity*
-
Piperazines / administration & dosage
-
Piperazines / therapeutic use
-
Piperazines / toxicity*
-
Placebos
-
Pyrimidines / administration & dosage
-
Pyrimidines / therapeutic use
-
Pyrimidines / toxicity*
Substances
-
Neuroprotective Agents
-
Piperazines
-
Placebos
-
Pyrimidines
-
sipatrigine